|
|
|
May 31, 2012 | Ensemble Therapeutics and Genentech are collaborating on macrocyclic drug candidates against targets identified by Genentech. The companies will use the Ensemblin collection of macrocycles and Ensemble's proprietary drug discovery platform. Ensemble will receive an undisclosed upfront payment, milestone payments, and possibly royalties. Mass High Tech
|
|
|